COVID-19 Health Evidence Summary No.29 by Millington, Kerry
   
1 
Evidence Summary 
y 
 
 
COVID-19  
Health Evidence Summary No.29 
Kerry Millington 
Liverpool School of Tropical Medicine (LSTM)  
30 April 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive 
summary of evidence. 
 
COVID-19 Preparedness and Response 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
30.04.2020 A SARS-CoV-2 
protein 
interaction map 
reveals targets 
for drug 
repurposing 
Nature | Article 
 Two sets of host factor targeting 
agents were identified that 
displayed antiviral activity 
 This approach of host-directed 
intervention as an antiviral 
strategy overcomes problems 
associated with drug resistance 
and could provide pan-viral 
therapies for future pandemics 
 Potential for co-therapy with 
drugs that directly target the 
virus, including remdesivir  
29.04.2020 The experiences 
of health-care 
providers during 
the COVID-19 
crisis in China: a 
qualitative study 
The Lancet 
Global Health | 
Article 
 A holistic picture of what 
healthcare providers in Wuhan, 
China experienced in the early 
stages of the pandemic 
 The intensive work drained 
health-care providers physically 
and emotionally who showed 
resilience and the spirit of 
professional dedication to 
overcome challenges 
 Sufficient PPE, reasonable work 
schedules, an effective 
communication environment, 
monitoring and supervision of 
2 
infection control, and 
professional psychological 
support are necessary to 
improving the experiences of 
health-care providers 
24.04.2020 Slum Health: 
Arresting 
COVID-19 and 
improving well-
being in urban 
informal 
settlements 
J Urban Health 
| Article 
 A set of practice and policy 
suggestions that aim to (1) 
dampen the spread of COVID-
19, (2) improve the likelihood of 
medical care for the urban poor 
whether or not they get infected, 
and (3) provide economic, 
social, and physical 
improvements and protection to 
improve long-term well-being  
  
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Description 
28.04.2020 COVI-PREG CHUV   International COVID-19 and 
Pregnancy   Registry 
28.04.2020 Accessibility Campaign – 
COVID-19 
International 
Disability 
Alliance 
  Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing compendium 
for low resource settings: a 
living document (edition 1) 
IDS Sanitation 
Learning Hub 
  
 Ongoing WHO Country & Technical 
Guidance 
WHO   
 Ongoing Inter-Agency Standing 
Committee (IASC) 
IASC   
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Comments, Editorials, Correspondence, Blogs, News 
Publication 
date 
Title/URL Journal | Publication type 
29.04.2020 COVID-19: Increased risk to the mental health and 
safety of women living with HIV in South Africa 
AIDS and Behaviour | 
Editorial 
24.04.2020 COVID-19-Compliant strategies for supporting 
treatment adherence among people living with HIV 
in sub-Saharan Africa 
AIDS and Behaviour | 
Editorial 
29.04.2020 Maintaining essential services in the time of 
COVID-19: vaccination delivery in low and middle-
income countries  
Center for Global 
Development | Blog 
23.04.2020 Disability, urban health equity, and the coronavirus 
pandemic: promoting cities for all 
J Urban Health  
29.04.2020 Keeping COVID-19 at bay in Africa The Lancet Respiratory 
Medicine | News 
29.04.2020 COVID-19 in Nigeria: a disease of hunger  The Lancet Respiratory 
Medicine | Spotlight 
29.04.2020 Use of the Demographic and Health Survey 
framework as a population surveillance strategy for 
COVID-19 
The Lancet Global Health 
| Correspondence 
29.04.2020 Focusing on health-care providers experiences in 
the COVID-19 crisis 
The Lancet Global Health 
| Comment 
27.04.2020 Covid-19: What do we know so far about a 
vaccine? 
BMJ | News 
29.04.2020 Hopes rise on a coronavirus drug remdesivir Nature | News 
  
4 
Tracking Dashboards 
Cases & 
deaths: Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
  Diagnostics   Treatments   Vaccines 
WHO sitreps WHO Africa Ghana   FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia   Serology-based 
tests for COVID-
19 
 US NIH 
registered 
clinical trials 
  Vaccine 
Centre 
LSHTM 
Johns Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
    Solidarity trial   
WEF 
  Sierra 
Leone 
    COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore       
Global 5050   UK       
CEBM, 
University of 
Oxford 
  US       
Humanitarian 
Data Exchange 
          
Information is 
Beautiful 
          
LSHTM           
HealthMap 
(cases) 
          
5 
The Commons 
Project 
          
C19 Resource Hubs 
Global  Regional 
& 
Country 
Academic 
journals & 
Publishers 
Global Health 
Institutes/Centres 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
The Lancet LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre 
for Global 
Infectious Disease 
Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
BMJ ODI SLH: 
Handwashing 
in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
 
  Rings HSG 
Resyst 
Reach 
Wellcome 
UN African 
Academy 
of 
Sciences 
Cochrane 
resources 
Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women   PLoS CMMID 
Repository 
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UNOCHA   Wiley 
Health 
Economics 
Norwegian 
Institute of Public 
Health 
    
UNHCR   Pre-prints 
medRxiv 
and 
bioRxiv 
CEBM, University 
of Oxford 
    
UNICEF      HEART     
UNESCO           
UN WFP           
GOARN           
World Bank           
COVID-19 
Narratives by 
David Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
          
WorldPop           
Flowminder           
COVID-END           
7 
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events  
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online learning 3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-
time training for the 
coronavirus disease 
outbreak 
Online learning Multiple self-
paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online learning 3 weeks | 4 
hours 
weekly study 
FutureLearn LSHTM/UK 
PHRST 
20 April 
2020 
COVID-19 
Diagnostics and 
Testing 
Online learning 3 weeks | 3 
hours 
weekly study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 
2020 
COVID-19 Critical 
Care: Understanding 
and Application 
Online learning 5 weeks | 1 
hour weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians of 
Edinburgh  
Available 
now 
COVID-19 
supporting online 
courses 
Online learning Multiple self-
paced 
course 
BMJ Learning 
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About this report 
This daily COVID-19 health evidence summary is based on 3 hours of desk-based research. K4D services are 
provided by a consortium of leading organisations working in international development, led by the Institute of 
Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield Centre for 
International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of Birmingham 
International Development Department (IDD) and the University of Manchester Humanitarian and Conflict 
Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for non-
commercial purposes only. K4D cannot be held responsible for errors, omissions or any 
consequences arising from the use of information contained in this health evidence summary. 
Any views and opinions expressed do not necessarily reflect those of DFID, K4D or any other 
contributing organisation.  
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